Vaccibody AS announced a private placement of 2,255,034 shares at a price of NOK 79.07 per share for the gross proceeds of NOK 178,305,538.38 on November 23, 2021. The transaction will include participation from Regeneron Pharmaceuticals, Inc.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
13.28 NOK | +0.30% | -0.97% | -37.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.94% | 393M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.07% | 22.18B | |
-16.67% | 21.2B | |
-9.77% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- VACC Stock
- News Nykode Therapeutics
- Vaccibody AS announced that it expects to receive NOK 178.305538 million in funding from Regeneron Pharmaceuticals, Inc.